Channel (CHRO)
$2.20
0.00 (0.00%)
CHRO Stock Quote Delayed 30 Minutes
CHRO Stock Earnings: Chromocell Therapeutics Reported Results for Q2 2024
Chromocell Therapeutics just reported results for the second quarter of 2024.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$2.05
Market Cap
13.26M
PE Ratio
-1.98
EPS
-1.1125
Volume (Avg. Vol.)
33,071
Day's Range
$2.03 - $2.29
52-Week Range
$0.45 - $3.82
Dividend & Yield
N/A (N/A)
